APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sclerotherapy

Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.

Selected research

Industry Growth & Trends

Global Sclerotherapy Industry Growth and Trends Forecast to 2032

20 December 2025104 pages

Choose your research edition.

Industry ResearchSclerotherapy Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Sclerotherapy Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Sclerotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sclerotherapy Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Sclerotherapy Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.

According to APO Research, the global Sclerotherapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Sclerotherapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sclerotherapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sclerotherapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sclerotherapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Sclerotherapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sclerotherapy Market by Company

BTG

Kreussler

LGM Pharma

Troikaa

Changan Tianyu group

Bioniche Pharma Group Ltd

Omega Pharmaceuticals

Angiodynamics

ENDO-FLEX

MTW ENDOSKOPIE

Cook Medical

Sclerotherapy Segment by Type

Detergents

Osmotic Agents

Chemical Irritants

Sclerotherapy Segment by Application

Venous Disease

Gastrointestinal Bleeding

Bronchopleural Fistula

Cystic Disease

Sclerotherapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sclerotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sclerotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sclerotherapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Sclerotherapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Sclerotherapy Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Sclerotherapy Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Sclerotherapy Market Share by Region (2021-2026) Table 4. Global Sclerotherapy Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Sclerotherapy Market Share by Region (2027-2032) Table 6. Global Sclerotherapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Sclerotherapy Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Sclerotherapy Market Size Share by Type (2021-2026) Table 9. Global Sclerotherapy Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Sclerotherapy Market Size Share Forecasted by Type (2027-2032) Table 11. North America Sclerotherapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Sclerotherapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Sclerotherapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Sclerotherapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Sclerotherapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Sclerotherapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Sclerotherapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Sclerotherapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Sclerotherapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Sclerotherapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Sclerotherapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Sclerotherapy Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Sclerotherapy Market Size Share by Application (2021-2026) Table 24. Global Sclerotherapy Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Sclerotherapy Market Size Share Forecasted by Application (2027-2032) Table 26. North America Sclerotherapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Sclerotherapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Sclerotherapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Sclerotherapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Sclerotherapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Sclerotherapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Sclerotherapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Sclerotherapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Sclerotherapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Sclerotherapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Sclerotherapy Industry Trends Table 37. Sclerotherapy Industry Drivers Table 38. Sclerotherapy Industry Opportunities and Challenges Table 39. Sclerotherapy Industry Restraints Table 40. Global Sclerotherapy Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Sclerotherapy Revenue Market Share by Company (2021-2026) Table 42. Global Sclerotherapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Sclerotherapy Key Company Headquarters & Area Served Table 44. Global Sclerotherapy Company, Product Type & Application Table 45. Global Sclerotherapy Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Sclerotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. BTG Company Information Table 49. BTG Business Overview Table 50. BTG Sclerotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. BTG Sclerotherapy Product Portfolio Table 52. BTG Recent Development Table 53. Kreussler Company Information Table 54. Kreussler Business Overview Table 55. Kreussler Sclerotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Kreussler Sclerotherapy Product Portfolio Table 57. Kreussler Recent Development Table 58. LGM Pharma Company Information Table 59. LGM Pharma Business Overview Table 60. LGM Pharma Sclerotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. LGM Pharma Sclerotherapy Product Portfolio Table 62. LGM Pharma Recent Development Table 63. Troikaa Company Information Table 64. Troikaa Business Overview Table 65. Troikaa Sclerotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Troikaa Sclerotherapy Product Portfolio Table 67. Troikaa Recent Development Table 68. Changan Tianyu group Company Information Table 69. Changan Tianyu group Business Overview Table 70. Changan Tianyu group Sclerotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Changan Tianyu group Sclerotherapy Product Portfolio Table 72. Changan Tianyu group Recent Development Table 73. Bioniche Pharma Group Ltd Company Information Table 74. Bioniche Pharma Group Ltd Business Overview Table 75. Bioniche Pharma Group Ltd Sclerotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Bioniche Pharma Group Ltd Sclerotherapy Product Portfolio Table 77. Bioniche Pharma Group Ltd Recent Development Table 78. Omega Pharmaceuticals Company Information Table 79. Omega Pharmaceuticals Business Overview Table 80. Omega Pharmaceuticals Sclerotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Omega Pharmaceuticals Sclerotherapy Product Portfolio Table 82. Omega Pharmaceuticals Recent Development Table 83. Angiodynamics Company Information Table 84. Angiodynamics Business Overview Table 85. Angiodynamics Sclerotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Angiodynamics Sclerotherapy Product Portfolio Table 87. Angiodynamics Recent Development Table 88. ENDO-FLEX Company Information Table 89. ENDO-FLEX Business Overview Table 90. ENDO-FLEX Sclerotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. ENDO-FLEX Sclerotherapy Product Portfolio Table 92. ENDO-FLEX Recent Development Table 93. MTW ENDOSKOPIE Company Information Table 94. MTW ENDOSKOPIE Business Overview Table 95. MTW ENDOSKOPIE Sclerotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. MTW ENDOSKOPIE Sclerotherapy Product Portfolio Table 97. MTW ENDOSKOPIE Recent Development Table 98. Cook Medical Company Information Table 99. Cook Medical Business Overview Table 100. Cook Medical Sclerotherapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Cook Medical Sclerotherapy Product Portfolio Table 102. Cook Medical Recent Development Table 103. North America Sclerotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Sclerotherapy Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Sclerotherapy Market Share by Country (2021-2026) Table 106. North America Sclerotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Sclerotherapy Market Share Forecast by Country (2027-2032) Table 108. Europe Sclerotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Sclerotherapy Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Sclerotherapy Market Share by Country (2021-2026) Table 111. Europe Sclerotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Sclerotherapy Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Sclerotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Sclerotherapy Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Sclerotherapy Market Share by Country (2021-2026) Table 116. Asia-Pacific Sclerotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Sclerotherapy Market Share Forecast by Country (2027-2032) Table 118. Latin America Sclerotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Sclerotherapy Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Sclerotherapy Market Share by Country (2021-2026) Table 121. Latin America Sclerotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Sclerotherapy Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Sclerotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Sclerotherapy Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Sclerotherapy Market Share by Country (2021-2026) Table 126. Middle East & Africa Sclerotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Sclerotherapy Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Sclerotherapy Product Image Figure 3. Global Sclerotherapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 5. Global Sclerotherapy Market Share by Region: 2025 VS 2032 Figure 6. Global Sclerotherapy Market Share by Region (2021-2032) Figure 7. North America Sclerotherapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Sclerotherapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Sclerotherapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Sclerotherapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Sclerotherapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Detergents Image Figure 13. Global Detergents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Osmotic Agents Image Figure 15. Global Osmotic Agents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Chemical Irritants Image Figure 17. Global Chemical Irritants Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Sclerotherapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Sclerotherapy Market Share by Type 2025 VS 2032 Figure 20. North America Sclerotherapy Market Size Share by Type (2021-2032) Figure 21. Europe Sclerotherapy Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Sclerotherapy Market Size Share by Type (2021-2032) Figure 23. Latin America Sclerotherapy Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Sclerotherapy Market Size Share by Type (2021-2032) Figure 25. Venous Disease Image Figure 26. Global Venous Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Gastrointestinal Bleeding Image Figure 28. Global Gastrointestinal Bleeding Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Bronchopleural Fistula Image Figure 30. Global Bronchopleural Fistula Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Cystic Disease Image Figure 32. Global Cystic Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Sclerotherapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Sclerotherapy Market Share by Application 2025 VS 2032 Figure 35. North America Sclerotherapy Market Size Share by Application (2021-2032) Figure 36. Europe Sclerotherapy Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Sclerotherapy Market Size Share by Application (2021-2032) Figure 38. Latin America Sclerotherapy Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Sclerotherapy Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Sclerotherapy Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Sclerotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Sclerotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Sclerotherapy Market Share by Country (2021-2032) Figure 45. Europe Sclerotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Sclerotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Sclerotherapy Market Share by Country (2021-2032) Figure 48. Asia-Pacific Sclerotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Sclerotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Sclerotherapy Market Share by Country (2021-2032) Figure 51. Latin America Sclerotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Sclerotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Sclerotherapy Market Share by Country (2021-2032) Figure 54. Middle East & Africa Sclerotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Sclerotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Sclerotherapy Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Detergents
  • Osmotic Agents
  • Chemical Irritants
Applications
  • Venous Disease
  • Gastrointestinal Bleeding
  • Bronchopleural Fistula
  • Cystic Disease
Companies covered
  • BTG
  • Kreussler
  • LGM Pharma
  • Troikaa
  • Changan Tianyu group
  • Bioniche Pharma Group Ltd
  • Omega Pharmaceuticals
  • Angiodynamics
  • ENDO-FLEX
  • MTW ENDOSKOPIE
  • Cook Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Sclerotherapy Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Sclerotherapy Market Size by Region (2021-2032)
  5. 1.4.1 Global Sclerotherapy Market Size by Region (2021-2026)
  6. 1.4.2 Global Sclerotherapy Market Size by Region (2027-2032)
  7. 1.5 Key Regions Sclerotherapy Market Size (2021-2032)
  8. 1.5.1 North America Sclerotherapy Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Sclerotherapy Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Sclerotherapy Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Sclerotherapy Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Sclerotherapy Market Size Growth Rate (2021-2032)
2 Sclerotherapy Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Detergents
  3. 2.1.2 Osmotic Agents
  4. 2.1.3 Chemical Irritants
  5. 2.2 Global Sclerotherapy Market Size by Type
  6. 2.2.1 Global Sclerotherapy Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Sclerotherapy Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Sclerotherapy Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Sclerotherapy Market Size by Regions
  10. 2.3.1 North America Sclerotherapy Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Sclerotherapy Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Sclerotherapy Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Sclerotherapy Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Sclerotherapy Market Size Breakdown by Type (2021-2026)
3 Sclerotherapy Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Venous Disease
  3. 3.1.2 Gastrointestinal Bleeding
  4. 3.1.3 Bronchopleural Fistula
  5. 3.1.4 Cystic Disease
  6. 3.2 Global Sclerotherapy Market Size by Application
  7. 3.2.1 Global Sclerotherapy Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Sclerotherapy Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Sclerotherapy Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Sclerotherapy Market Size by Regions
  11. 3.3.1 North America Sclerotherapy Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Sclerotherapy Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Sclerotherapy Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Sclerotherapy Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Sclerotherapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Sclerotherapy Industry Trends
  2. 4.2 Sclerotherapy Industry Drivers
  3. 4.3 Sclerotherapy Industry Opportunities and Challenges
  4. 4.4 Sclerotherapy Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Sclerotherapy Revenue (2021-2026)
  2. 5.2 Global Sclerotherapy Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Sclerotherapy Key Company Headquarters & Area Served
  4. 5.4 Global Sclerotherapy Company, Product Type & Application
  5. 5.5 Global Sclerotherapy Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Sclerotherapy Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Sclerotherapy Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Sclerotherapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 BTG
  2. 6.1.1 BTG Company Information
  3. 6.1.2 BTG Business Overview
  4. 6.1.3 BTG Sclerotherapy Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 BTG Sclerotherapy Product Portfolio
  6. 6.1.5 BTG Recent Developments
  7. 6.2 Kreussler
  8. 6.2.1 Kreussler Company Information
  9. 6.2.2 Kreussler Business Overview
  10. 6.2.3 Kreussler Sclerotherapy Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Kreussler Sclerotherapy Product Portfolio
  12. 6.2.5 Kreussler Recent Developments
  13. 6.3 LGM Pharma
  14. 6.3.1 LGM Pharma Company Information
  15. 6.3.2 LGM Pharma Business Overview
  16. 6.3.3 LGM Pharma Sclerotherapy Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 LGM Pharma Sclerotherapy Product Portfolio
  18. 6.3.5 LGM Pharma Recent Developments
  19. 6.4 Troikaa
  20. 6.4.1 Troikaa Company Information
  21. 6.4.2 Troikaa Business Overview
  22. 6.4.3 Troikaa Sclerotherapy Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Troikaa Sclerotherapy Product Portfolio
  24. 6.4.5 Troikaa Recent Developments
  25. 6.5 Changan Tianyu group
  26. 6.5.1 Changan Tianyu group Company Information
  27. 6.5.2 Changan Tianyu group Business Overview
  28. 6.5.3 Changan Tianyu group Sclerotherapy Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Changan Tianyu group Sclerotherapy Product Portfolio
  30. 6.5.5 Changan Tianyu group Recent Developments
  31. 6.6 Bioniche Pharma Group Ltd
  32. 6.6.1 Bioniche Pharma Group Ltd Company Information
  33. 6.6.2 Bioniche Pharma Group Ltd Business Overview
  34. 6.6.3 Bioniche Pharma Group Ltd Sclerotherapy Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Bioniche Pharma Group Ltd Sclerotherapy Product Portfolio
  36. 6.6.5 Bioniche Pharma Group Ltd Recent Developments
  37. 6.7 Omega Pharmaceuticals
  38. 6.7.1 Omega Pharmaceuticals Company Information
  39. 6.7.2 Omega Pharmaceuticals Business Overview
  40. 6.7.3 Omega Pharmaceuticals Sclerotherapy Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Omega Pharmaceuticals Sclerotherapy Product Portfolio
  42. 6.7.5 Omega Pharmaceuticals Recent Developments
  43. 6.8 Angiodynamics
  44. 6.8.1 Angiodynamics Company Information
  45. 6.8.2 Angiodynamics Business Overview
  46. 6.8.3 Angiodynamics Sclerotherapy Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Angiodynamics Sclerotherapy Product Portfolio
  48. 6.8.5 Angiodynamics Recent Developments
  49. 6.9 ENDO-FLEX
  50. 6.9.1 ENDO-FLEX Company Information
  51. 6.9.2 ENDO-FLEX Business Overview
  52. 6.9.3 ENDO-FLEX Sclerotherapy Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 ENDO-FLEX Sclerotherapy Product Portfolio
  54. 6.9.5 ENDO-FLEX Recent Developments
  55. 6.10 MTW ENDOSKOPIE
  56. 6.10.1 MTW ENDOSKOPIE Company Information
  57. 6.10.2 MTW ENDOSKOPIE Business Overview
  58. 6.10.3 MTW ENDOSKOPIE Sclerotherapy Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 MTW ENDOSKOPIE Sclerotherapy Product Portfolio
  60. 6.10.5 MTW ENDOSKOPIE Recent Developments
  61. 6.11 Cook Medical
  62. 6.11.1 Cook Medical Company Information
  63. 6.11.2 Cook Medical Business Overview
  64. 6.11.3 Cook Medical Sclerotherapy Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Cook Medical Sclerotherapy Product Portfolio
  66. 6.11.5 Cook Medical Recent Developments
7 North America
  1. 7.1 North America Sclerotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Sclerotherapy Market Size by Country (2021-2026)
  3. 7.3 North America Sclerotherapy Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Sclerotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Sclerotherapy Market Size by Country (2021-2026)
  3. 8.3 Europe Sclerotherapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Sclerotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Sclerotherapy Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Sclerotherapy Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Sclerotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Sclerotherapy Market Size by Country (2021-2026)
  3. 10.3 South America Sclerotherapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Sclerotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Sclerotherapy Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Sclerotherapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst